Related Experiment Video
Updated: Jul 19, 2026
04:30
Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
C-reactive protein in aortic valve disease
Pedro L Sanchez1, Anna Maria Mazzone
1Instituto de Ciencias del Corazón (ICICOR), Hospital Clínico Universitario de Valladolid, C/Ramón y Cajal, 47005, Valladolid, Spain. pedrolsanchez@secardiologia.es
Cardiovascular Ultrasound
|October 18, 2006
Summary
Aortic valve stenosis shares inflammatory processes with atherosclerosis. Systemic inflammation markers like C-reactive protein (CRP) may help monitor the progression of aortic valve stenosis.
Area of Science:
- Cardiovascular Medicine
- Pathology
Background:
- Aortic valve disease encompasses conditions from mild leaflet thickening (aortic sclerosis) to severe calcified aortic stenosis.
- Degenerative aortic valve stenosis is a progressive process involving valve modification.
- This process shares similarities with atherosclerosis, including risk factors, inflammation, and calcification.
Purpose of the Study:
- To explore the link between systemic inflammation and degenerative aortic valve stenosis.
- To investigate the potential of inflammatory markers for monitoring stenosis progression.
Main Methods:
- Analysis of systemic inflammation markers, such as C-reactive protein (CRP), in patients with degenerative aortic valve stenosis.
- Comparison of inflammatory profiles with those observed in atherosclerosis.
Main Results:
- Systemic signs of inflammation, including elevated wall and serum CRP, are present in patients with degenerative aortic valve stenosis.
- These inflammatory markers are similar to those found in atherosclerosis.
Conclusions:
- Degenerative aortic valve stenosis may represent a common inflammatory disease process shared with atherosclerosis.
- Systemic inflammatory markers like CRP could be valuable for monitoring the progression of aortic valve stenosis.
More Related Videos
Related Concept Videos
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:15Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...